Podoplanin immunostaining in cutaneous apocrine carcinoma and in cutaneous metastasis from the breast

Applied Immunohistochemistry and Molecular Morphology

Volumn 18, Issue 6, 2010, Pages 573-574

  Fernandez Flores, Angel ^a  

^a HOSPITAL EL BIERZO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; GROSS CYSTIC DISEASE FLUID PROTEIN 15; MAMMAGLOBIN; PODOPLANIN; PROTEIN P63; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOCRINE CARCINOMA; BREAST CARCINOMA; CANCER LOCALIZATION; CUTANEOUS APOCRINE CARCINOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; PRIORITY JOURNAL; SKIN CARCINOMA; SKIN METASTASIS; SKIN TUMOR; SWEAT GLAND;

ANTIBODIES; BREAST NEOPLASMS; CARCINOMA, DUCTAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; SKIN NEOPLASMS; SWEAT GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UTEROGLOBIN;

EID: 78650516697     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181e9fe74     Document Type: Letter

References (13)

1. Liang H, Wu H, Giorgadze TA, et al. Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin. Am J Surg Pathol. 2007;31:304-310. (Pubitemid 46175033)
2. Requena L, Kutzner H, Hurt MA, et al. Malignant tumours with apocrine and eccrine differentiation. In: LeBoit PE, Burg G, Weedon D, et al. eds. World Health Organization Classification of Tumours. Pathology and Genetics. Skin Tumours. 1st ed. Lyon: IARC Press; 2006:25-138.
3. Yoshida A, Kodama Y, Hatanaka S, et al. Apocrine adenocarcinoma of the bilateral axillae. Acta Pathol Jpn. 1991;41:927-932.
4. Nishikawa Y, Tokushashi Y, Saito Y, et al. A case of apocrine adenocarcinoma associated with hamartomatous apocrine gland hyperplasia of both axillae. Am J Surg Pathol. 1994;18:832-836. (Pubitemid 24229406)
5. Wick MR, Ockner DM, Mills SE, et al. Homologous carcinomas of the breast, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma. Am J Clin Pathol. 1998;109:75-84.
6. Cameseille-Teijeiro J, Cameseille-Teijeiro JF. Homologous carcinomas of the breast and skin. Am J Clin Pathol. 1999;111: 709-712.
7. Miyamoto T, Hagari Y, Inoue S, et al. Axillary apocrine carcinoma with benign apocrine tumours: a case report involving a pathological and immunohistochemical study and review of the literature. J Clin Pathol. 2005;58:757-761. (Pubitemid 40956834)
8. Ivan D, Nash JW, Prieto VG, et al. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to the skin. J Cutan Pathol. 2007;34:474-480. (Pubitemid 46791198)
9. Marks A, Sutherlans DR, Bailey D, et al. Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Br J Cancer. 1999;80:569-578. (Pubitemid 29213215)
10. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposis sarcoma and a subset of angiosarcomas. Mod Pathol. 2002;15:434-440. (Pubitemid 34326952)
11. Kahn HJ, Marks A. A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest. 2002;82:1255-1257. (Pubitemid 35014860)
12. Fernandez-Flores A. Mammaglobin immunostaining in the differential diagnosis between cutaneous apocrine carcinoma and cutaneous metastasis from breast carcinoma. Cesk Patol. 2009;45:108-112.
13. Fernandez-Flores A. The elusive differential diagnosis of cutaneous apocrine adenocarcinoma versus metastasis: the current role of clinical correlation. Acta Dermatovenerol Alp Panonica Adriat. 2009;18:141-142.